Showing results (701-710 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|March 22, 2006
A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude miceDominique Ledoux, Yamina Hamma-Kourbali, Mélanie Di Benedetto, et al.Anti-Cancer Drugs|October 1, 2004
Controlling cancer by restricting arginine availability--arginine-catabolizing enzymes as anticancer agentsDenys N WheatleyAnti-Cancer Drugs|October 1, 2004
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cellsK Chisholm, B J Bray, R J RosengrenAnti-Cancer Drugs|September 16, 2005
Hypoxia inducible factor-1: a novel target for cancer therapyVladimir E Belozerov, Erwin G Van MeirAnti-Cancer Drugs|September 16, 2005
Taurolidine--a new drug with anti-tumor and anti-angiogenic effectsChristoph A Jacobi, Charalambos Menenakos, Chris BraumannAnti-Cancer Drugs|September 16, 2005
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbiditiesOlivier Mir, Jérôme Alexandre, Stanislas Ropert, et al.Anti-Cancer Drugs|September 16, 2005
Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trialAndreas Schneeweiss, Florian Schuetz, Christian Rudlowski, et al.Anti-Cancer Drugs|July 20, 2005
Cytarabine-induced lung injury: case reportPetros Kopterides, Michalis Lignos, Spyros Mentzelopoulos, et al.Anti-Cancer Drugs|July 20, 2005
Tumor-targeted and activated bioconjugates for improved camptothecin deliveryPankaj V Paranjpe, Stanley Stein, Patrick J SinkoAnti-Cancer Drugs|June 3, 2005
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell linesSybille Wittich, Hans Scherf, Changping Xie, et al.Pageof 464